These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 11703979)

  • 1. A simple scheme to initiate oral anticoagulant treatment in outpatients with nonrheumatic atrial fibrillation.
    Pengo V; Biasiolo A; Pegoraro C
    Am J Cardiol; 2001 Nov; 88(10):1214-6. PubMed ID: 11703979
    [No Abstract]   [Full Text] [Related]  

  • 2. Can a simple warfarin initiation scheme predict the maintenance dose in patients with nonrheumatic atrial fibrillation?
    Culhane NS
    J Fam Pract; 2002 Feb; 51(2):175. PubMed ID: 11978219
    [No Abstract]   [Full Text] [Related]  

  • 3. Suboptimal Anticoagulant Management in Japanese Patients with Nonvalvular Atrial Fibrillation Receiving Warfarin for Stroke Prevention.
    Hirano T; Kaneko H; Mishina S; Wang F; Morita S
    J Stroke Cerebrovasc Dis; 2017 Oct; 26(10):2102-2110. PubMed ID: 28532651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral anticoagulant treatment in very elderly patients with atrial fibrillation.
    Pengo V
    Compr Ther; 2001; 27(1):7-10. PubMed ID: 11280859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [From warfarin to new oral anticoagulants in clinical practice. What is the future of anticoagulant therapy in atrial fibrillation?].
    Colivicchi F
    Monaldi Arch Chest Dis; 2013 Jun; 80(2):55-6. PubMed ID: 24494406
    [No Abstract]   [Full Text] [Related]  

  • 6. Sustainability and impact of warfarin compliance for atrial fibrillation.
    Kuo S; Burrill J
    Med Health R I; 2007 Dec; 90(12):378-80. PubMed ID: 18314828
    [No Abstract]   [Full Text] [Related]  

  • 7. Contra: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Caveats regarding use of oral anticoagulant therapy among elderly patients with atrial fibrillation.
    Hylek EM
    Thromb Haemost; 2008 Jul; 100(1):16-7. PubMed ID: 18612532
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation.
    Hylek EM; Go AS; Chang Y; Jensvold NG; Henault LE; Selby JV; Singer DE
    N Engl J Med; 2003 Sep; 349(11):1019-26. PubMed ID: 12968085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. National Trends in Ambulatory Oral Anticoagulant Use.
    Barnes GD; Lucas E; Alexander GC; Goldberger ZD
    Am J Med; 2015 Dec; 128(12):1300-5.e2. PubMed ID: 26144101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Causes of Ischemic Stroke in Patients with Non-Valvular Atrial Fibrillation.
    Nakamura A; Kuroda J; Ago T; Hata J; Matsuo R; Arakawa S; Kuwashiro T; Yasaka M; Okada Y; Kitazono T; Kamouchi M;
    Cerebrovasc Dis; 2016; 42(3-4):196-204. PubMed ID: 27111222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Prediction Model for Time in Therapeutic Range While on Warfarin in Newly Diagnosed Atrial Fibrillation.
    Williams BA; Evans MA; Honushefsky AM; Berger PB
    J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29025746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral anticoagulant therapy for patients with atrial fibrillation--an update.
    Hylek EM
    Thromb Res; 2008; 123 Suppl 1():S46-9. PubMed ID: 18809205
    [No Abstract]   [Full Text] [Related]  

  • 13. Assessment of Oral Anticoagulant Use in Residents of Long-Term Care Homes: Evidence for Contemporary Suboptimal Use.
    Rojas-Fernandez CH; Goh J; Hartwick J; Auber R; Zarrin A; Warkentin M; Hudani Z
    Ann Pharmacother; 2017 Dec; 51(12):1053-1062. PubMed ID: 28745065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of fixed minidose warfarin in the prevention of thromboembolism and vascular death in nonrheumatic atrial fibrillation.
    Pengo V; Zasso A; Barbero F; Banzato A; Nante G; Parissenti L; John N; Noventa F; Dalla Volta S
    Am J Cardiol; 1998 Aug; 82(4):433-7. PubMed ID: 9723629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circadian variations in laboratory measurements of coagulation assays after administration of rivaroxaban or warfarin in patients with nonvalvular atrial fibrillation.
    Hitaka Y; Ogawa M; Zhang B; Goto S; Nagata Y; Morii J; Imaizumi S; Yasuda T; Matsumoto N; Matsunaga A; Saku K
    J Cardiol; 2016 Dec; 68(6):529-535. PubMed ID: 26987789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. D-Dimer versus International Normalized Ratio of Prothrombin Time in Ischemic Stroke Patients Treated with Sufficient Warfarin.
    Yamamoto R; Nakae Y; Tanaka F; Johkura K
    J Stroke Cerebrovasc Dis; 2016 Jul; 25(7):1781-1785. PubMed ID: 27103270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Warfarin or acenocoumarol is better in the anticoagulant treatment of chronic atrial fibrillation?].
    Lengyel M;
    Orv Hetil; 2004 Dec; 145(52):2619-21. PubMed ID: 15724697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medium- to long-term persistence with non-vitamin-K oral anticoagulants in patients with atrial fibrillation: Australian experience.
    Simons LA; Ortiz M; Freedman B; Waterhouse BJ; Colquhoun D
    Curr Med Res Opin; 2017 Jul; 33(7):1337-1341. PubMed ID: 28425296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prothrombin time on admission in patients with cardioembolic stroke and intracranial hemorrhage occurring during warfarin treatment in the direct oral anticoagulant era].
    Okumura K; Hagii J; Metoki N; Saito S; Shiroto H; Yasujima M; Tomita H
    Rinsho Shinkeigaku; 2016 May; 56(5):309-17. PubMed ID: 27151227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemoptysis due to aspirin treatment alternative to warfarin therapy in a patient with atrial fibrillation.
    Song W; Cao J; Xu Y; Han Z; Wen H; Cui X
    Intern Med; 2015; 54(20):2615-8. PubMed ID: 26466698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.